Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Fully sequenced samples of complimentary DNA synthesized from single-stranded, non-mammalian RNA. A wide variety of gene inserts are available. Ideal for use in gene cloning, as gene probes, and cDNA library in creation.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Mindeudesivir hydrobromide is a deuterated version of Remdesivir, a highly orally active nucleoside antiviral effective against SARS-CoV-2 and respiratory syncytial virus (RSV). It maintains the antiviral activity of Remdesivir against COVID-19 and is the first domestically produced deuterium targeting COVID-19. This product is for research use only.
Highly orally active nucleoside antiviral
Effective against SARS-CoV-2 and respiratory syncytial virus (RSV)
Maintains antiviral activity against COVID-19
First domestically produced deuterium targeting COVID-19
For research use only
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Anatabine dicitrate is a tobacco alkaloid capable of crossing the blood-brain barrier. It acts as a potent α4β2 nAChR agonist. This compound inhibits NF-κB activation, which leads to a reduction in amyloid-β (Aβ) production by preventing the β-cleavage of amyloid precursor protein (APP). Additionally, Anatabine dicitrate demonstrates anti-inflammatory effects and shows potential for the treatment of neurodegenerative disorders.
Can cross the blood-brain barrier.
Potent α4β2 nAChR agonist.
Inhibits NF-κB activation.
Lowers amyloid-β (Aβ) production by preventing the β-cleavage of APP.
Possesses anti-inflammatory effects.
Has potential for neurodegenerative disorders treatment.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
DRB18 is a potent pan-class GLUT inhibitor that modifies energy-related metabolism in A549 cells by altering metabolite abundance in glucose-related pathways. This can result in G1/S phase arrest, increased oxidative stress, and necrotic cell death. It has demonstrated anti-tumor activity.
Potent pan-class GLUT inhibitor
Modifies energy-related metabolism in A549 cells
Leads to G1/S phase arrest
Increases oxidative stress
Causes necrotic cell death
Demonstrates anti-tumor activity
Reduces glucose uptake in HEK293 cell lines
Inhibits tumor volume and weight in xenografted tumors
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Ximelagatran (H 376/95) is an orally active thrombin inhibitor that selectively and competitively inhibits both free and clot-bound thrombin Ximelagatran is an anticoagulant agent with a rapid onset of anticoagulant effect predictable dose-dependent pharmcokinetics and pharmacodynamics[1 [2
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More